Full Text View
Tabular View
No Study Results Posted
Related Studies
Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer
This study has been completed.
Study NCT00020176   Information provided by National Cancer Institute (NCI)

First Received on July 11, 2001.   Last Updated on February 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
filgrastim
therapeutic allogeneic lymphocytes
cyclophosphamide
cyclosporine
fludarabine phosphate
Additional drug interventions recognized in this trial
Cyclosporins
Fludarabine
Fludarabine monophosphate
Lenograstim
Vidarabine
More general drug interventions related to this trial
Adjuvants, Immunologic
Alkylating Agents
Anti-Infective Agents
Antifungal Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Antiviral Agents
Dermatologic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services